Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostate Cryoablation and Cyclophosphamide With ADT and Novel ARIs in Metastatic Prostate Cancer
NCT06854250Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2025
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in prostate cancer (PCa), sponsored by Sun Yat-sen University. Started Mar 2025; status: recruiting.
02
Drugs
cyclophosphamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06854250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06854250.